Ledger.Open graph →
SEC Form D · filed February 10, 2022

Indapta Therapeutics Inc

Offering
$67.1M
Sold
$33.6M
Exemption
Rule 506(b)
Industry
Other Technology
Location
HOUSTON, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Fabio Pucci · Houston, TXDirectorLaura Stoppel · Houston, TXDirectorMark Frohlich · Houston, TXExec · DirectorRonald Martell · San Francisco, CADirectorGuy Dipierro · WALTHAM, MAExecLori Hu · Houston, TXDirectorMark Frohlich · Seattle, WAExec · DirectorRonald Martell · Houston, TXDirectorFabio Pucci · Houston, TXDirectorLaura Stoppel · Houston, TXDirectorGuy Dipierro · WALTHAM, MAExecLori Hu · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗